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A Bright Spot in the Study of Inﬂammation in
Human Atherosclerosis*Guillermo J. Tearney, MD, PHDM acrophages are key inﬂammatory cellsthat are involved at every phase ofatherosclerosis, from its genesis to plaque
rupture and coronary thrombosis. Study of these cells
in living patients is therefore critical to improving our
understanding of human atherosclerosis. With this
knowledge, for example, visualization of macrophage
patterns within coronary ﬁbroatheroma may provide
unique signatures for diagnosing the atherosclerotic
lesions that are most likely to cause a coronary event.
Given the importance of macrophages and the
potential impact of their identiﬁcation in vivo, the
ﬁnding that intravascular optical coherence tomog-
raphy (IVOCT) can be used to visualize accumulation
of these cells in ﬁbroatheromas was of great interest
to many in the ﬁeld (1). The key original observation
was that ﬁbroatheroma macrophages exhibit a
stronger optical coherence tomography (OCT) signal
intensity and variance than their surroundings. This
ﬁnding has now been observed by other expert pa-
thologists who compared OCT images versus histo-
logical ﬁndings (2). Also supporting this fact are
reports using higher-resolution micro-OCT, which
have proven that foamy macrophages exhibit strong
OCT signals (3,4), and published positive clinical
correlations between IVOCT metrics of ﬁbroatheroma
macrophage content and peripheral white blood cell
count (5), high-sensitivity C-reactive protein (6),*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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conducted research sponsored by Canon Inc. and Merck.positive remodeling (7), cap rupture (8), and clinical
presentation. As a result of this body of work in the
ﬁeld of IVOCT, there is wide consensus that this
technique is capable of visualizing macrophages
within ﬁbroatheroma. As stated in the 2012 IVOCT
Consensus Document in JACC (9): “Macrophages may
be seen by IVOCT as signal-rich, distinct, or conﬂuent
punctate regions that exceed the intensity of back-
ground speckle noise. Macrophages should only be
evaluated in the context of a ﬁbroatheroma.”
The 2012 IVOCT Consensus Document in JACC (9)
also highlights the following important features and
caveats: “Macrophages may often be seen at the
boundary between the bottom of the cap and the top of
a necrotic core. Macrophages attenuate the IVOCT
light signiﬁcantly, and as a result, superﬁcial macro-
phages can shadow underlying tissue, giving it the
appearance of a necrotic core. Macrophage accumu-
lations may also be confused on occasion with
microcalciﬁcations, cholesterol crystals, or internal or
external elastic membrane. Noting the linear appear-
ance of the cholesterol crystals or laminae can mini-
mize some of these misinterpretations. It should be
noted that high axial and lateral resolutions are
desired for detection of macrophage accumulations.
Whether or not IVOCT can identify individual macro-
phages is not known.”
In terms of macrophage quantiﬁcation, our group
developed a simple parameter that is ameasure of local
OCT signal intensity and local variance, termed the
normalized standard deviation (NSD):s=ðSmax  SminÞ,
in which s is the SD, Smin is the minimum signal in the
image, and Smax is the maximum signal (1). Impor-
tantly, NSD was only developed and tested to deter-
mine macrophage content in plaque because it was
recognized that other artery wall structures (e.g., the
internal or external elastic laminae, calciﬁcation, adi-
pocytes) would also generate a high NSD. In this
initial study, NSD was found to have a good degree
of correlation to the percentage area of CD68þ staining
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74in cadaver ﬁbroatheroma using linear OCT data
(R ¼ 0.84, p < 0.0001) and a moderate degree of
correlation using logarithmic OCT data (R ¼ 0.47, p <
0.05). Multiple groups have now used NSD to study
macrophages seen by IVOCT (6,8,10).SEE PAGE 63In this issue of iJACC, Phipps et al. (11) describe
research to investigate “bright spots” seen by using
IVOCT and their relation to macrophages or other
artery wall components. These investigators used a
new method for segmenting out bright spots in the
IVOCT image that employs an intensity threshold
on the normalized logarithm IVOCT data which ac-
counts for the distance between the catheter and
the surface of the vessel. The authors implemented
this algorithm on IVOCT images obtained from 14
cadaver coronary arteries. Bright spots were identi-
ﬁed and compared with matching histological ﬁnd-
ings, including CD68 immunohistochemistry.
Overall, the algorithm of Phipps et al. (11) performed
reasonably well compared with matching CD68þ his-
tology, demonstrating a sensitivity of 80% and a
speciﬁcity of 49%. The overall accuracy was similar to
that of an expert IVOCT reader’s delineation of mac-
rophages, which had a sensitivity of 46% and a spec-
iﬁcity of 76%; total agreement between the algorithm
and expert was only 53%, however. This low overlap in
a sense illustrates the value of a combined approach:
the quantitative algorithm was more sensitive to
subtle bright spots, whereas the human eye was more
capable of disregarding nonmacrophage results. As
mentioned in the authors’ discussion, a suitable
approach may be to use their algorithm to identify
candidate bright spots. Subsequently, another algo-
rithm/expert reader can determine whether these
bright spots are within plaque or ﬁbroatheroma.
When IVOCT bright spots determined by using the
algorithm of Phipps et al. (11) were compared with
corresponding CD68þ staining and microscopic mor-
phology, the ﬁndings support the ﬁeld’s current un-
derstanding about the capability of IVOCT to image
macrophage accumulations. In particular:
1. The majority (57%) of bright spot regions identiﬁed
anywhere in the artery walls were associated with
macrophages. This high percentage is remarkable
because these bright spots were detected in all
anatomical/architectural regions within the artery
wall, including the adventitia, media, and intima.
The analysis also evaluated IVOCT data within
calciﬁed plates of ﬁbrocalciﬁc plaques that clearly
do not contain intact macrophages. Again, speci-
ﬁcity would increase signiﬁcantly if this analysiswas restricted to noncalciﬁed ﬁbroatheromatous
plaque, as is the standard in the ﬁeld.
2. Bright spots in the context of thin-cap ﬁbroather-
oma were caused by macrophages in 94% of cases.
This result also supports the concept that the
speciﬁcity of IVOCT is high for macrophages in
ﬁbroatheroma. This ﬁnding is signiﬁcant because
thin-cap ﬁbroatheroma is the predominant plaque
presumed to be at risk for cap rupture, and
inﬂammation within the cap is thought to be an
important predisposing risk factor for this event.
3. Not all bright spots are caused by macrophages;
some are caused by other artery wall or plaque
components, such as cholesterol crystals, elastin/
collagen, and microcalciﬁcations. These results
should help with the understanding of the inter-
pretation of bright regions within IVOCT images.
This information may be useful when training
IVOCT readers to avoid diagnostic pitfalls and
consider other sources of high IVOCT signal re-
gions. It clearly is important to look at the
morphological context in which these regions are
identiﬁed to evaluate whether these signal-rich
spots or regions are macrophages.
In addition to conﬁrming our current understand-
ing of macrophage diagnosis in IVOCT, the in-
vestigators (1) uncovered interesting new ﬁndings
about bright spots and their relation to macrophages.
For example, they discovered that some areas with
CD68 positivity did not exhibit bright spots according
to IVOCT. One plausible hypothesis for this result,
suggested by the authors, is that there may be
different types of macrophages (e.g., M1 vs. M2
macrophages) that differ in their backscattering
properties. Shadowing by macrophages, a well-
known phenomenon in IVOCT images, was further
expanded upon here by the discovery that macro-
phages which elicited shadowing were also
frequently associated with other particulate tissues,
such as microcalciﬁcations and cholesterol crystals.
This ﬁnding suggests that phagocytosis of these
components may cause higher IVOCT light scattering
and attenuation.
Although the work of Phipps et al. (11) has nicely
added to the literature, conﬁrming our understanding
of IVOCT imaging of macrophage accumulations and
further identifying potential pitfalls in diagnosis,
it is important to remember that even equipped
with accurate macrophage-ﬁnding methods, we must
still consider the context of these bright spots before
ascribing clinical or scientiﬁc relevance. Indeed, it
may be better to assess which regions are inﬂamed
and which regions are not and what are the structural
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75and functional implications of this inﬂammation. For
example, an isolated few bright spots are probably
not clinically signiﬁcant, whereas a large accumula-
tion of many bright spots within a thin ﬁbrous cap
may be of more concern.
Details about coronary wall patterns of macro-
phage inﬁltration in patients have previously been
difﬁcult to obtain. The recognition that IVOCT can
visualize macrophage accumulations and its conﬁr-
mation in the paper by Phipps et al. (11) are “bright
spots” in our quest to study human coronaryatherosclerosis and diagnose vulnerable plaque in
patients. Continued pursuit of such research will
further build on IVOCT’s diagnostic capabilities in
the coronary wall so that we may advance our
understanding of inﬂammation in this disease and
ultimately provide better care to our patients.
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